Risk of Severe Morbidity and Mortality of Coronavirus Disease 2019 (COVID-19) Among Patients Taking Antihypertensive Medications
- Funded by American Heart Association
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
American Heart AssociationPrincipal Investigator
Unspecified Jaejin AnResearch Location
United States of AmericaLead Research Institution
Kaiser Permanente Southern CaliforniaResearch Priority Alignment
N/A
Research Category
Clinical characterisation and managementResearch Subcategory
Disease pathogenesisSpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
UnspecifiedBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
This team will evaluate antihypertensive medication treatment in patients with confirmed COVID-19 infection and high blood pressure and their results could have an immediate impact on clinical guidance for patient care